Related Experiment Video
Updated: Aug 6, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Anemia and cardiovascular disease in diabetic nephropathy
Samy I McFarlane1, Moro O Salifu, John Makaryus
1Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, State University of New York Health Science Center at Brooklyn, Kings County Hospital Center, 450 Clarkson Avenue, Box 50, Brooklyn, NY 11203-2098, USA. smcfarlane@downstate.edu
Insights
Anemia is a significant risk factor for cardiovascular disease (CVD) in patients with diabetes and chronic kidney disease (CKD). Addressing anemia may help reduce CVD complications in this vulnerable population.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a leading cause of death in patients with diabetes and chronic kidney disease (CKD).
- Diabetes is the primary cause of CKD and kidney failure globally.
- Identifying modifiable CVD risk factors in diabetic CKD patients is crucial.
Purpose of the Study:
- To review the evidence linking anemia to CVD in patients with diabetic nephropathy.
- To explore the pathophysiologic mechanisms behind this association.
- To highlight anemia as a potential modifiable CVD risk factor.
Main Methods:
- Review of epidemiologic evidence.
- Analysis of pathophysiologic mechanisms.
- Synthesis of current research findings.
Main Results:
- Anemia is increasingly recognized as a CVD risk factor in diabetic nephropathy.
- Anemia is often more severe and occurs earlier in CKD patients with diabetes.
- This review consolidates evidence on anemia's role in CVD risk.
Conclusions:
- Anemia is a significant CVD risk factor in patients with diabetic nephropathy.
- Managing anemia may mitigate CVD risk in this high-risk group.
- Further research is warranted to confirm anemia as a modifiable target.
Abstract:
Cardiovascular disease (CVD) is the major cause of morbidity and mortality in people with diabetes and in those with chronic kidney disease (CKD). Diabetes, occurring in epidemic proportions in the United States and worldwide, is also the leading cause of CKD and kidney failure. Identification of modifiable risk factors for CVD in patients with diabetes and CKD is thus of paramount importance. Anemia is increasingly recognized as a potential CVD risk factor in patients with diabetic nephropathy, in whom it is generally more severe and occurs at an earlier stage of CKD. In this review, we discuss the epidemiologic evidence, pathophysiologic mechanisms, and the current research findings, highlighting the role of anemia as a potential modifiable risk factor for CVD in patients with diabetic nephropathy, a particularly vulnerable population for CVD.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Retinopathy
Diabetic Neuropathy
Chronic Kidney Disease IV: Nursing Management
Complications of Diabetes Mellitus
